5 big analyst cuts: First Solar slashed to Sell ahead of Q1 | Pro Recap

This post was originally published on this site

https://i-invdn-com.investing.com/news/fa8a2f803ea2ddf92359d55091dcde0a_M.jpg

Investing.com — Here is your daily Pro Recap of the biggest analyst cuts you may have missed since Friday’s close.

Citi downgraded First Solar (NASDAQ:FSLR) to Sell/High Risk from Neutral and cut its price target to $194.00 from $220.00 given its belief that the company’s long-term outlook for margins and growth will draw increased scrutiny as the global supply of Si-based modules rises while the cost drops. Shares are trading more than 2% lower premarket today.

Get this news in real time with InvestingPro for informed, data-driven decisions.

The company is set to report its Q1/23 earnings this Thursday, after the market close. Consensus estimates stand at $1.01 for EPS and $716.79 million for revenues.

C3.ai (NYSE:AI) shares are trading around 5% lower premarket today after Wolfe Research downgraded the stock to Underperform from Peerperform with a price target of $14.00.

The company reported its Q3/23 earnings last month, with both EPS and revenues coming in above the consensus estimates. For the full year, the company guided revenues in the range of $264M-$266M, compared to the consensus of $261M.

3 more downgrades

Truist Securities downgraded Regions Financial (NYSE:RF) to Hold from Buy with a price target of $20.00.

Shares fell nearly 3% on Friday after the company reported its Q1 results, with EPS of $0.62 and revenue of $1.95 billion missing the consensus estimates.

Raymond James downgraded Tandem Diabetes Care (NASDAQ:TNDM) to Market Perform from Outperform. Shares are down nearly 2% premarket today.

Last week, the company announced Control-IQ Technology Meta-analysis, which demonstrated positive clinical impact of automatic correction bolusing on glucose control in people with Type 1 diabetes.

Goldman Sachs downgraded Kingsoft Cloud (NASDAQ:KC) to Sell from Neutral while raising its price target to $5.10 from $4.00.

The company reported its Q4 results last month, with both EPS and revenues beating the consensus estimates.

InvestingPro | Be The First To Know